Source: Modern Pathology. Unidade: FMRP
Subjects: ALGORITMOS, BIOMARCADORES, ESTUDOS DE COORTES, SEQUENCIAMENTO GENÉTICO, IMAGEM DIGITAL, NEOPLASIAS PROSTÁTICAS
ABNT
HARMON, Stephanie A. et al. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts. Modern Pathology, v. 34, p. 478-489, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41379-020-00674-w. Acesso em: 10 set. 2024.APA
Harmon, S. A., Patel, P. G., Sanford, T. H., Caven, I., Iseman, R., Vidotto, T., et al. (2021). High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts. Modern Pathology, 34, 478-489. doi:10.1038/s41379-020-00674-wNLM
Harmon SA, Patel PG, Sanford TH, Caven I, Iseman R, Vidotto T, Picanço C, Squire JA, Masoudi S, Mehralivand S, Choyke PL, Berman DM, Turkbey B, Jamaspishvili T. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts [Internet]. Modern Pathology. 2021 ; 34 478-489.[citado 2024 set. 10 ] Available from: https://doi.org/10.1038/s41379-020-00674-wVancouver
Harmon SA, Patel PG, Sanford TH, Caven I, Iseman R, Vidotto T, Picanço C, Squire JA, Masoudi S, Mehralivand S, Choyke PL, Berman DM, Turkbey B, Jamaspishvili T. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts [Internet]. Modern Pathology. 2021 ; 34 478-489.[citado 2024 set. 10 ] Available from: https://doi.org/10.1038/s41379-020-00674-w